Denali Therapeutics Inc.
ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF
Last updated:
Abstract:
In one aspect, antibodies that specifically bind to a human triggering receptor expressed on myeloid cells 2 (TREM2) protein are provided. In some embodiments, the antibody decreases levels of soluble TREM2 (sTREM2). In some embodiments, the antibody enhances TREM2 activity.
Status:
Application
Type:
Utility
Filling date:
16 Aug 2021
Issue date:
21 Apr 2022